Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • ymc
    replied
    Originally posted by SNPsaurus View Post
    It is probably extra difficult to identify a 3-fold duplication in 10% of the tumor cells, since it will look like normal diploid levels + a small increase over the whole sample. And you wouldn't be able to distinguish a 3-fold duplication in 10% of the tumor cells from a 30-fold duplication in 1% of the tumor cells.

    Some programs may report it anyway, but I do not know of any.
    Thanks for your reply. Presumably, I suppose the prevailing FISH/IHC method to detect HER2 amplification/overexpression also suffer from the same problem?

    Leave a comment:


  • SNPsaurus
    replied
    It is probably extra difficult to identify a 3-fold duplication in 10% of the tumor cells, since it will look like normal diploid levels + a small increase over the whole sample. And you wouldn't be able to distinguish a 3-fold duplication in 10% of the tumor cells from a 30-fold duplication in 1% of the tumor cells.

    Some programs may report it anyway, but I do not know of any.

    Leave a comment:


  • ymc
    started a topic Any program reports somatic CNVs with tumor fraction?

    Any program reports somatic CNVs with tumor fraction?

    I noticed Mutect reports somatic mutations with tumor fraction (ie the percentage of tumor cells that has said mutation). I think this makes sense because it reflects tumor heterogeneity.

    But when I tried ExomeCNV for somatic CNV. It doesn't report tumor fraction. (or maybe it does but how to do that?) Do you know any somatic CNV program that reports tumor fraction?

    Thanks

Latest Articles

Collapse

  • seqadmin
    Advanced Tools Transforming the Field of Cytogenomics
    by seqadmin


    At the intersection of cytogenetics and genomics lies the exciting field of cytogenomics. It focuses on studying chromosomes at a molecular scale, involving techniques that analyze either the whole genome or particular DNA sequences to examine variations in structure and behavior at the chromosomal or subchromosomal level. By integrating cytogenetic techniques with genomic analysis, researchers can effectively investigate chromosomal abnormalities related to diseases, particularly...
    09-26-2023, 06:26 AM
  • seqadmin
    How RNA-Seq is Transforming Cancer Studies
    by seqadmin



    Cancer research has been transformed through numerous molecular techniques, with RNA sequencing (RNA-seq) playing a crucial role in understanding the complexity of the disease. Maša Ivin, Ph.D., Scientific Writer at Lexogen, and Yvonne Goepel Ph.D., Product Manager at Lexogen, remarked that “The high-throughput nature of RNA-seq allows for rapid profiling and deep exploration of the transcriptome.” They emphasized its indispensable role in cancer research, aiding in biomarker...
    09-07-2023, 11:15 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Today, 06:47 AM
0 responses
7 views
0 likes
Last Post seqadmin  
Started by seqadmin, Yesterday, 09:36 AM
0 responses
10 views
0 likes
Last Post seqadmin  
Started by seqadmin, 10-02-2023, 07:14 AM
0 responses
20 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-29-2023, 09:38 AM
0 responses
16 views
0 likes
Last Post seqadmin  
Working...
X